Showing results (461-470 of 615) with videos related to
Sort By:
Pageof 62
Bone Marrow Transplantation|November 24, 2004
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningM E D Flowers, F Traina, B Storer, et al.Blood|October 1, 1996
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantationW I Bensinger, R Clift, P Martin, et al.Blood|August 15, 1994
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptorC Anasetti, J A Hansen, T A Waldmann, et al.Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.Blood|November 15, 1994
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factorsR Storb, R F Raff, F R Appelbaum, et al.Blood|May 1, 1989
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemiaK M Sullivan, P L Weiden, R Storb, et al.Bone Marrow Transplantation|October 1, 1987
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.Blood|February 1, 1981
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionK M Sullivan, H M Shulman, R Storb, et al.The New England Journal of Medicine|March 30, 1989
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasmsK M Sullivan, R Storb, C D Buckner, et al.Bone Marrow Transplantation|January 1, 1991
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancyJ Nemunaitis, J W Singer, C D Buckner, et al.Pageof 62